Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04608617 · ClinicalTrials.gov registry record
SYNCHRONISE: LVO Triage Timing and Outcome Study
A clinical trial, sponsored by Viz.ai.
- Completed
- Registry status
- 600
- Enrollment target
NCT04608617 is a clinical trial that has completed, run by Viz.ai. The registered enrollment target is 600 participants.
The verdict
NCT04608617 has completed, sponsored by Viz.ai.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the impact of Viz LVO in hospital systems with non-interventional and interventional (spoke and hub) stroke centers on the timing and outcomes of patients with suspected acute ischemic stroke indicated for mechanical thrombectomy.
Interventions
- DEVICE Viz LVO (De Novo Number DEN170073)
- OTHER Baseline Effectiveness Cohort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2021-03-09 |
| Est. Completion | 2023-04-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04608617
The ClinicalTrials.gov registry entry for NCT04608617 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Viz.ai, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Viz LVO (De Novo Number DEN170073) is the first listed.
NCT04608617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04608617 about?
NCT04608617 is a clinical study titled "SYNCHRONISE: LVO Triage Timing and Outcome Study". The objective of this study is to evaluate the impact of Viz LVO in hospital systems with non-interventional and interventional (spoke and hub) stroke centers on the timing and outcomes of patients with suspected acute ischemic stroke indicated for mechanical thrombectomy.
What is the current status of trial NCT04608617?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2021-03-09. Estimated completion is 2023-04-26.
What interventions are being tested in trial NCT04608617?
The interventions under investigation include: Viz LVO (De Novo Number DEN170073) (DEVICE), Baseline Effectiveness Cohort (OTHER).
Who is sponsoring clinical trial NCT04608617?
This trial is sponsored by Viz.ai, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.